Current Medicinal Chemistry

Editor-in-Chief

Atta-ur-Rahman, FRS
(32052 citations)
Kings College
University of Cambridge
Cambridge
(UK)

Nobel Laureates on Editorial Board

Prof. John Gurdon
(UK)

Prof. Jean-Marie Lehn
(France)

Prof. Ferid Murad
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 28 Issue: 11, April 2021



Meet Our Editorial Board Member

Volume:28   Issue: 11
Pp: 2081-2082
Paola Perego
DOI: 10.2174/092986732811210416084503
Published on: 15 April, 2021



Drug Repurposing in Cancer: Now and Beyond

Volume:28   Issue: 11
Pp: 2083-2084
Ali H. Eid
DOI: 10.2174/092986732811210416084626
Published on: 15 April, 2021



Perspectives on Drug Repurposing

Volume:28   Issue: 11
Pp: 2085-2099
Alejandro Schcolnik-Cabrera, Daniel Juárez-López and Alfonso Duenas-Gonzalez*
DOI: 10.2174/0929867327666200831141337
Published on: 31 August, 2020



Deep Learning in Drug Target Interaction Prediction: Current and Future Perspectives

Volume:28   Issue: 11
Pp: 2100-2113
Karim Abbasi, Parvin Razzaghi, Antti Poso, Saber Ghanbari-Ara and Ali Masoudi-Nejad*
DOI: 10.2174/0929867327666200907141016
Published on: 07 September, 2020



Drug Repurposing in Oncology, an Attractive Opportunity for Novel Combinatorial Regimens

Volume:28   Issue: 11
Pp: 2114-2136
Paolo Falvo, Stefania Orecchioni, Stefania Roma, Alessandro Raveane and Francesco Bertolini*
DOI: 10.2174/0929867327999200817104912
Published on: 16 August, 2020



Antidepressants and Antipsychotic Agents as Repurposable Oncological Drug Candidates

Volume:28   Issue: 11
Pp: 2137-2174
Michał Antoszczak, Anna Markowska, Janina Markowska and Adam Huczyński*
DOI: 10.2174/0929867327666200907141452
Published on: 07 September, 2020



Drug Repurposing in Oncology: Current Evidence and Future Direction

Volume:28   Issue: 11
Pp: 2175-2194
Zhenzhan Zhang, Jianguang Ji* and Hao Liu*
DOI: 10.2174/0929867327999200820124111
Published on: 20 August, 2020



Drug Repositioning for the Treatment of Hematologic Disease: Limits, Challenges and Future Perspectives

Volume:28   Issue: 11
Pp: 2195-2217
Alessandro Allegra, Chiara Imbesi, Alessandra Bitto* and Roberta Ettari
DOI: 10.2174/0929867327999200817102154
Published on: 16 August, 2020



Repurposing of Acriflavine to Target Chronic Myeloid Leukemia Treatment

Volume:28   Issue: 11
Pp: 2218-2233
Rawan Nehme, Rawan Hallal, Maya El Dor, Firas Kobeissy, Fabrice Gouilleux, Frédéric Mazurier and Kazem Zibara*
DOI: 10.2174/0929867327666200908114411
Published on: 07 September, 2020



Repurposing Anticancer Drugs for the Treatment of Idiopathic Pulmonary Fibrosis and Antifibrotic Drugs for the Treatment of Cancer: State of the Art

Volume:28   Issue: 11
Pp: 2234-2247
Panagiotis Paliogiannis, Sara Solveig Fois, Alessandro Giuseppe Fois, Antonio Cossu, Giuseppe Palmieri and Gianfranco Pintus*
DOI: 10.2174/0929867327999200730173748
Published on: 30 July, 2020



Sildenafil in Combination Therapy against Cancer: A Literature Review

Volume:28   Issue: 11
Pp: 2248-2259
Rabah Iratni* and Mohammed Akli Ayoub*
DOI: 10.2174/0929867327666200730165338
Published on: 30 July, 2020



The Emerging Role of COX-2, 15-LOX and PPARγ in Metabolic Diseases and Cancer: An Introduction to Novel Multi-target Directed Ligands (MTDLs)

Volume:28   Issue: 11
Pp: 2260-2300
Rana A. Alaaeddine, Perihan A. Elzahhar, Ibrahim AlZaim, Wassim Abou-Kheir, Ahmed S.F. Belal* and Ahmed F. El-Yazbi*
DOI: 10.2174/0929867327999200820173853
Published on: 20 August, 2020